ICU Medical (ICUI) Tops Q2 EPS Views; Boosts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
ICU Medical, Inc. Announces Second Quarter 2015 Results
August 10, 2015 4:02 PM EDTSAN CLEMENTE, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq: ICUI) ("ICU Medical"), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced financial results for the second quarter ended June 30, 2015.
Second Quarter 2015 Results
Second quarter 2015 revenue was $83.8 million, compared to $78.7 million in the same period last year. GAAP net income for the second quarter of 2015 was $13.6 million, or $0.83 per diluted share, as compared to GAAP net income of $5.9 million, or $0.38 per... More



